Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Members of Congress who traded OCUL

No member of Congress has reported a trade in Ocular Therapeutix, Inc since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.